vs
Cooper Companies (The)（COO）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是Cooper Companies (The)的2.0倍（$2.1B vs $1.1B），Roper Technologies净利率更高（15.8% vs 7.9%，领先7.9%），Roper Technologies同比增速更快（11.3% vs 4.6%），Roper Technologies自由现金流更多（$507.0M vs $149.9M），过去两年Roper Technologies的营收复合增速更高（10.5% vs 6.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
COO vs ROP — 直观对比
营收规模更大
ROP
是对方的2.0倍
$1.1B
营收增速更快
ROP
高出6.7%
4.6%
净利率更高
ROP
高出7.9%
7.9%
自由现金流更多
ROP
多$357.1M
$149.9M
两年增速更快
ROP
近两年复合增速
6.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $2.1B |
| 净利润 | $84.6M | $331.0M |
| 毛利率 | 61.1% | 69.4% |
| 营业利润率 | 13.2% | 27.2% |
| 净利率 | 7.9% | 15.8% |
| 营收同比 | 4.6% | 11.3% |
| 净利润同比 | -28.0% | 53.7% |
| 每股收益（稀释后） | $0.42 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.0B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $964.7M | $1.9B | ||
| Q4 24 | $1.0B | $1.9B | ||
| Q3 24 | $1.0B | $1.8B | ||
| Q2 24 | $942.6M | $1.7B |
净利润COOROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $84.6M | $428.4M | ||
| Q3 25 | $98.3M | $398.5M | ||
| Q2 25 | $87.7M | $378.3M | ||
| Q1 25 | $104.3M | $331.1M | ||
| Q4 24 | $117.5M | $462.3M | ||
| Q3 24 | $104.7M | $367.9M | ||
| Q2 24 | $88.9M | $337.1M |
毛利率COOROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 61.1% | 69.5% | ||
| Q3 25 | 65.3% | 69.5% | ||
| Q2 25 | 67.8% | 69.2% | ||
| Q1 25 | 68.4% | 68.7% | ||
| Q4 24 | 66.5% | 68.3% | ||
| Q3 24 | 66.1% | 69.2% | ||
| Q2 24 | 67.0% | 69.5% |
营业利润率COOROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | 13.2% | 28.6% | ||
| Q3 25 | 16.6% | 28.4% | ||
| Q2 25 | 18.4% | 28.2% | ||
| Q1 25 | 18.9% | 27.9% | ||
| Q4 24 | 19.5% | 28.0% | ||
| Q3 24 | 19.2% | 28.1% | ||
| Q2 24 | 17.2% | 28.8% |
净利率COOROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | 7.9% | 20.8% | ||
| Q3 25 | 9.3% | 19.8% | ||
| Q2 25 | 8.7% | 19.5% | ||
| Q1 25 | 10.8% | 17.6% | ||
| Q4 24 | 11.5% | 24.6% | ||
| Q3 24 | 10.4% | 20.8% | ||
| Q2 24 | 9.4% | 19.6% |
每股收益（稀释后）COOROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $0.42 | $3.97 | ||
| Q3 25 | $0.49 | $3.68 | ||
| Q2 25 | $0.44 | $3.49 | ||
| Q1 25 | $0.52 | $3.06 | ||
| Q4 24 | $0.59 | $4.29 | ||
| Q3 24 | $0.52 | $3.40 | ||
| Q2 24 | $0.44 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $382.9M |
| 总债务越低越好 | $2.5B | $9.7B |
| 股东权益账面价值 | $8.2B | $18.8B |
| 总资产 | $12.4B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资COOROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $110.6M | $297.4M | ||
| Q3 25 | $124.9M | $320.0M | ||
| Q2 25 | $116.2M | $242.4M | ||
| Q1 25 | $100.9M | $372.8M | ||
| Q4 24 | $107.6M | $188.2M | ||
| Q3 24 | $109.7M | $269.6M | ||
| Q2 24 | $112.4M | $251.5M |
总债务COOROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $2.5B | $9.3B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | $7.6B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — |
股东权益COOROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $8.2B | $19.9B | ||
| Q3 25 | $8.4B | $20.0B | ||
| Q2 25 | $8.3B | $19.6B | ||
| Q1 25 | $8.1B | $19.2B | ||
| Q4 24 | $8.1B | $18.9B | ||
| Q3 24 | $7.9B | $18.5B | ||
| Q2 24 | $7.8B | $18.1B |
总资产COOROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $12.4B | $34.6B | ||
| Q3 25 | $12.4B | $34.6B | ||
| Q2 25 | $12.4B | $33.2B | ||
| Q1 25 | $12.2B | $31.4B | ||
| Q4 24 | $12.3B | $31.3B | ||
| Q3 24 | $12.1B | $31.6B | ||
| Q2 24 | $12.0B | $29.8B |
负债/权益比COOROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 0.30× | 0.47× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | 0.40× | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $507.0M |
| 自由现金流率自由现金流/营收 | 14.1% | 24.2% |
| 资本支出强度资本支出/营收 | 9.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOROP
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $738.0M | ||
| Q3 25 | $261.4M | $869.5M | ||
| Q2 25 | $96.2M | $404.1M | ||
| Q1 25 | $190.6M | $528.7M | ||
| Q4 24 | $268.1M | $722.2M | ||
| Q3 24 | $207.5M | $755.4M | ||
| Q2 24 | $111.0M | $384.1M |
自由现金流COOROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $36.9M | — |
自由现金流率COOROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 3.9% | — |
资本支出强度COOROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 7.9% | — |
现金转化率COOROP
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 1.72× | ||
| Q3 25 | 2.66× | 2.18× | ||
| Q2 25 | 1.10× | 1.07× | ||
| Q1 25 | 1.83× | 1.60× | ||
| Q4 24 | 2.28× | 1.56× | ||
| Q3 24 | 1.98× | 2.05× | ||
| Q2 24 | 1.25× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
ROP
暂无分部数据
